What move does the options market price into Allogene Therapeutics's report?

Implied ±12.6%, either direction.

How often does Allogene Therapeutics move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

ALLONasdaqBiological Products, (No Diagnostic Substances)

Allogene Therapeutics, Inc. (ALLO) earnings date, market-implied expected move, and options open interest by expiry

1.13

+0.04 · +3.67%

Regular session11:52 ET

Open1.09Volume10.1MMkt cap$376.6MEPS-0.67

Day1.09 – 1.13100%52-wk1.04 – 4.463%

ALLO

Allogene Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±12.6%implied · report alone

8Q avg ±6.5%·×1.93·rich

0.951.23

straddle ±23.4%

spot 1.09exp Nov 20ATM strike 1ATM straddle 0.30IV 158%

Nov 2 closereport share · term structure

Expected move

Inputs

Next report

Nov 5

after close · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

−4.35%

vs ±13.3% implied · ×0.33

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Linked news

3hPFE · supplierPfizer posts Q3 net income of $3,242 million, revenue $16,583 million
6dCLLS · supplierCellectis shows 70% in vivo APOC3 editing and 76% triglyceride reduction with .HEAL-101
46dNTRA · supplierNatera Stock Has Excellent Technical ‘DNA’ as NTRA Sets a New All-Time High

News

Largest filed tie

13F top-10 QoQ

+65.28%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

209 managers

Top fund weight

0.24%

ALLO weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Allogene Therapeutics (ALLO) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±24.2%
avg realized: ±6.5%

Nov 7 '24Nov 7 '24confirmed±25.2%▼−3.45%×0.14

Mar 13 '25Mar 13 '25confirmed±23.8%▲+2.65%×0.11

May 13 '25May 13 '25confirmed±21.3%▼−15.68%×0.74

Aug 13 '25Aug 13 '25confirmed±39.7%▲+2.88%×0.07

Q3 FY25Nov 6 '25confirmed±23.5%▲+12.38%×0.53

Q1 FY26Mar 12 '26confirmed±33.1%▼−2.83%×0.09

May 13 '26May 13 '26confirmed±14.0%▼−8.15%×0.58

Q2 FY26Aug 12 '26confirmed±13.3%▼−4.35%×0.33

quarterimplied−40%0+40%realized×

Q2 FY26±13.3%▼−4.35%×0.33

May '26±14.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Oct 26 close

0.18OI · 2 expiries · Oct 26 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1,0160%Nov 2017d5,586+1%

4650%Feb 19108d0.076,6970%0.07

ExpiryPutsCallsP/C

Nov 2017d1,0160%5,586+1%0.18

Feb 19108d4650%6,6970%0.07

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±23.4%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−919.76%as filednet margin

Revenue$5M—

Gross profit$5M100.00%—

Operating income−$47M−1011.21%−1.80%

Pre-tax income−$43M−0.16%

Net income−$43M−919.76%−0.16%

Cost of revenue$0—

Operating expenses$52M+11.86%

Other income$4M+21.75%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 2 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 11:45 ET

Intraday

Event sensitivity

PPI ×1.70· ±6.8% vs ±4.0% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±6.8%7 of 10×1.70

GDPgross domestic product±4.0%8 of 19×1.01

NFPjobs report±3.7%4 of 10×0.94

FOMCrate decision±3.7%8 of 24×0.92

CPROFcorporate profits±3.5%5 of 12×0.88

PCEpersonal income & outlays±3.4%6 of 19×0.85

CPIconsumer prices±3.3%3 of 10×0.83

Bar = avg |move| to ±7% · tick = ±4.0% avg day · ×base = |move| ÷ ±4.0% · min 6 releases

Earnings history

EPS -0.13 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-0.13	—
Q1 FY26	Mar 12 '26 · confirmed	-0.18	—
Q3 FY25	Nov 6 '25 · confirmed	-0.19	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod